Oscar Health Inc. (OSCR) Tops Q4 EPS by 9c

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.05), $0.09 better than the analyst estimate of ($1.14). Revenue for the quarter came in at $995 million versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance